HSPGX
Price
$33.90
Change
+$0.53 (+1.59%)
Updated
Jun 2 closing price
Net Assets
1.49B
VISGX
Price
$100.64
Change
+$0.72 (+0.72%)
Updated
Jun 2 closing price
Net Assets
42.8B
Interact to see
Advertisement

HSPGX vs VISGX

Header iconHSPGX vs VISGX Comparison
Open Charts HSPGX vs VISGXBanner chart's image
HSPGX vs VISGX Comparison Chart in %
View a ticker or compare two or three
VS
HSPGX vs. VISGX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSPGX is a Buy and VISGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISGX has more cash in the bank: 42.8B vs. HSPGX (1.49B). VISGX pays higher dividends than HSPGX: VISGX (0.34) vs HSPGX (0.00). HSPGX was incepted earlier than VISGX: HSPGX (34 years) vs VISGX (28 years). HSPGX (1.04) is less costly to investors than VISGX (0.19). HSPGX is a more actively managed with annual turnover of: 45.00 vs. VISGX (24.00). VISGX has a lower initial minimum investment than HSPGX: VISGX (0) vs HSPGX (2000). HSPGX annual gain was more profitable for investors over the last year : 47.85 vs. VISGX (34.40). VISGX return over 5 years is better than : 30.62 vs. HSPGX (-1.33).
HSPGXVISGXHSPGX / VISGX
Total Expense Ratio1.020.19537%
Annual Report Gross Expense Ratio1.040.19547%
Fund Existence34 years28 years-
Gain YTD24.05217.759135%
Front Load5%N/A-
Min. Initial Investment20000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.49B42.8B3%
Annual Yield % from dividends0.000.34-
Returns for 1 year47.8534.40139%
Returns for 3 years55.4361.4490%
Returns for 5 years-1.3330.62-4%
Returns for 10 years87.86190.0646%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RERBX63.02N/A
N/A
American Funds EUPAC R2
GOGFX45.07N/A
N/A
Victory Sycamore Small Company Opp R
SGQAX48.41N/A
N/A
DWS International Opportunities A
PHLQX46.73N/A
N/A
PGIM Jennison Health Sciences R6
DLQIX15.32N/A
N/A
BNY Mellon Large Cap Equity I